Search bioRxiv⌕ Search

Biology subjects

Neill, S.

Publications and source records attributed to Neill, S..

2 recordsLinked to original sources

Label-Free, Real-Time, In Vivo Optical Biopsy with a Handheld Quantitative Phase Microscope

In this work we develop and demonstrate the utility of a compact, handheld quantitative phase imaging microscope that enables label-free, in vivo optical imaging of bulk tissues with clear cellular and subcellular histological detail in real-time. The proposed device overcomes significant challenges in optical imaging for in vivo applications, particularly for clinical human use. The approach uses quantitative oblique back illumination microscopy (qOBM) to obtain quantitative phase information of opaque samples using epi-illumination. The compact handheld probe achieves 0.8 {micro}m lateral resolution, 5 {micro}m axial resolution, 300 {micro}m X 300 {micro}m field of view, and operates at 25Hz in a wide-field (non-scanning) configuration, enabling real-time imaging. The probe is also inexpensive and has no moving components, making it robust. The utility of the probe is demonstrated in (1) human skin in vivo, (2) brain tumor tissue ex vivo from a murine tumor model and from discarded human tissue from neurosurgery, and (3) in vivo using healthy brain tissue from a large animal model (swine), simulating neurosurgical conditions. Given the clear cellular and subcellular histological detail (i.e., "optical biopsy") obtained in real-time, combined with the ease-of-use and low-cost of the system, the proposed device has significant implications for a broad range of clinical applications.

bioengineering↗

Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation

The global network of fridges and freezers known as the "cold chain" can account for a significant proportion of the total cost of vaccination and is susceptible to failure. Cost-efficient techniques to enhance stability of vaccines could prevent such losses and improve vaccination coverage, particularly in low income countries. We have previously reported a novel, potentially less expensive thermostabilisation approach using a combination of simple sugars and glass micro-fibrous matrix, achieving an excellent recovery of vaccines after storage at supraphysiological temperatures. This matrix is, however, prone to fragmentation and currently not suitable for clinical translation. Here, we report an investigation of alternative, potentially GMP compatible, fibrous matrices. A number of commercially-available matrices permitted good protein recovery, quality of sugar glass and moisture content of the dried product but did not achieve the thermostabilisation performance of the original glass fibre matrix. We therefore further investigated physical and chemical characteristics of the glass fibre matrix and its components. Our investigation shows that the polyvinyl alcohol present in the glass fibre matrix assists vaccine stability. This finding enabled us to develop a custom-produced matrix with encouraging performance, as an initial step towards a biocompatible matrix for clinical translation. We discuss the path to transfer of the technology into clinical use, including potential obstacles.

pharmacology and toxicology↗